Search Results
Dec 15, 2025, 17:31 ET Gene Therapies for Cardiomyopathies Market Poised for Rapid Expansion During the Forecast Period (2025-2034) with Advancements in AAV and CRISPR Platforms | DelveInsight
operational highlights, reported participation in the FDA's Development Readiness Pilot (CDRP) program to accelerate Chemistry, Manufacturing, and Controls (CMC) registration readiness and expects final alignment on the LX2006 registration study in the late third quarter to early fourth quarter 2025.In
More news about: DelveInsight Business Research, LLP
Dec 15, 2025, 16:19 ET Commercial Metals Completes Acquisition of Foley Products Company
IRVING, Texas, Dec. 15, 2025 /PRNewswire/ -- Commercial Metals Company (NYSE: CMC) ("CMC" or the "Company") today announced that it has successfully completed the acquisition of Foley Products Company, LLC ("Foley") for a cash purchase
More news about: Commercial Metals Company
Dec 15, 2025, 13:36 ET 21% TLX PLUNGE: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures
first the SEC apparently questioning the development disclosures, and then the FDA alleged to have rejected a BLA based on fundamental CMC (Chemistry, Manufacturing, and Controls) and Form 483 deficiencies at the third-party manufacturers," said
More news about: Hagens Berman Sobol Shapiro LLP
Dec 15, 2025, 01:28 ET Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.
synthesis and corresponding bioassays. With our subsidiary, Langhua Pharma, we offer our worldwide pharmaceutical and biotech partners a one-stop integrated CMC (Chemical, Manufacturing, and Control) service from preclinical to commercial manufacturing. Additionally, Viva embedded an equity for service (EFS)
More news about: Viva Biotech
Dec 15, 2025, 01:06 ET Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.
synthesis and corresponding bioassays. With our subsidiary, Langhua Pharma, we offer our worldwide pharmaceutical and biotech partners a one-stop integrated CMC (Chemical, Manufacturing, and Control) service from preclinical to commercial manufacturing. Additionally, Viva embedded an equity for service (EFS)
More news about: Viva Biotech
Dec 12, 2025, 11:30 ET TLX DEADLINE: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 - TLX
the Biologics License Application for its product TLX250-CDx, which identified "deficiencies relating to the Chemistry, Manufacturing, and Controls (CMC) package." The FDA additionally "documented notices of deficiency (Form 483) issued to two third-party manufacturing and supply chain partners that will
More news about: Faruqi & Faruqi, LLP
Dec 11, 2025, 22:33 ET 21% TLX PLUNGE: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures
first the SEC apparently questioning the development disclosures, and then the FDA alleged to have rejected a BLA based on fundamental CMC (Chemistry, Manufacturing, and Controls) and Form 483 deficiencies at the third-party manufacturers," said
More news about: Hagens Berman Sobol Shapiro LLP
Dec 11, 2025, 08:32 ET Sen-Jam Pharmaceutical Secures Major Strategic Partnership with TASK Clinical to Fund Two-Thirds of Phase 3 Trial for SJP-001
corporate venture partner/CMO, driving formulation, CMC, and FDA submission readinessRute Fernandes guiding global market expansion and commercialization strategyKVK Tech has made significant progress in the formulation development and CMC work for SJP-001, including the manufacturing
More news about: Sen-Jam Pharmaceutical
Dec 11, 2025, 08:00 ET HanchorBio Announces Oral Presentation of HCB101 at the ESMO Immuno-Oncology Congress 2025
several in vivo tumor animal models. By advancing breakthroughs in multi-functional, innovative molecular configurations in R&D and improving CMC manufacturing processes, HanchorBio develops transformative medicines to address unmet medical needs. For more information, please visit:
More news about: HanchorBio Inc.
Dec 10, 2025, 06:40 ET CMC Named to Newsweek's America's Most Responsible Companies 2026 List
-- Commercial Metals Company (NYSE: CMC) today announced that it has once again been recognized on Newsweek's America's Most Responsible Companies list, earning a place among the top-performing companies for 2026. This marks the fourth consecutive year that CMC has received this honor. The annual
More news about: Commercial Metals Company
Dec 09, 2025, 12:57 ET TLX LAWSUIT DEADLINE: Hagens Berman Urges Telix Investors to Act by Jan. 9 Over Alleged Dual Regulatory Failures: SEC Subpoena & FDA CRL on CMC/Supply Chain
August 28, 2025, the FDA rejected the Zircaix (TLX250-CDx) application, citing deficiencies in Chemistry, Manufacturing, and Controls (CMC) and documented Form 483 deficiencies at third-party manufacturers.
More news about: Hagens Berman Sobol Shapiro LLP
Dec 09, 2025, 08:38 ET Sen-Jam Pharmaceutical Appoints Global Life Sciences Leader Rute Fernandes as Executive Advisor to Accelerate Commercialization Pathways
pipeline, following recent commercial and clinical advances, including the increasingly valuable corporate venture/Chemistry, Manufacturing & Controls (CMC) partnership with
More news about: Sen-Jam Pharmaceutical
Dec 08, 2025, 16:15 ET CMC Announces First Quarter Fiscal 2026 Conference Call Webcast Details
www.cmc.com. About CMCCMC is an innovative solutions provider helping build a stronger, safer, and more sustainable world. Through an extensive manufacturing network
More news about: Commercial Metals Company
Dec 08, 2025, 07:00 ET HanchorBio Presents First-in-Human Data of HCB101 Monotherapy in Relapsed/Refractory Non-Hodgkin Lymphoma at ASH 2025
several in vivo tumor animal models. By advancing breakthroughs in multi-functional, innovative molecular configurations in R&D and improving CMC manufacturing processes, HanchorBio develops transformative medicines to address unmet medical needs. For more information, please visit:
More news about: HanchorBio Inc.
Dec 07, 2025, 21:00 ET Median PFS Trending Beyond One Year: Leads Biolabs' LBL-034 Showcases Breakthrough Clinical Data in Oral Presentation at the 2025 ASH Annual Meeting
bispecific antibody portfolios.We have established integrated capabilities across early discovery, translational medicine, clinical development, CMC and business development. The innovative nature and competitive strengths of our drug candidates, coupled with our global perspectives, proactive strategy,
More news about: Leads Biolabs
Dec 05, 2025, 11:18 ET SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals
the Biologics License Application for its product TLX250-CDx, which identified "deficiencies relating to the Chemistry, Manufacturing, and Controls (CMC) package." The FDA additionally "documented notices of deficiency (Form 483) issued to two third-party manufacturing and supply chain partners that will
More news about: Faruqi & Faruqi, LLP
Dec 05, 2025, 08:15 ET TLX LAWSUIT DEADLINE: Hagens Berman Urges Telix Investors to Act by Jan. 9 Over Alleged Dual Regulatory Failures: SEC Subpoena & FDA CRL on CMC/Supply Chain
August 28, 2025, the FDA rejected the Zircaix (TLX250-CDx) application, citing deficiencies in Chemistry, Manufacturing, and Controls (CMC) and documented Form 483 deficiencies at third-party manufacturers.
More news about: Hagens Berman Sobol Shapiro LLP
Dec 03, 2025, 17:39 ET TLX LAWSUIT DEADLINE: Hagens Berman Urges Telix Investors to Act by Jan. 9 Over Alleged Dual Regulatory Failures: SEC Subpoena & FDA CRL on CMC/Supply Chain
August 28, 2025, the FDA rejected the Zircaix (TLX250-CDx) application, citing deficiencies in Chemistry, Manufacturing, and Controls (CMC) and documented Form 483 deficiencies at third-party manufacturers.
More news about: Hagens Berman Sobol Shapiro LLP
Dec 03, 2025, 09:00 ET Benuvia Operations Announces Strategic Partnership with Cannovation Clinical Research Partners to Deliver Fully Integrated Solutions for Controlled-Substance Therapeutics
The collaboration combines Benuvia's end-to-end capabilities in controlled-substance manufacturing, analytical testing, and CMC development with CCRP's expertise in preclinical and clinical research, regulatory strategy, and global trial execution. Through this partnership, pharmaceutical
More news about: Benuvia Operations, LLC
Dec 03, 2025, 08:30 ET Xtalks Announces its Life Science Webinar Calendar for December 2025
CHAINDec 4 - Using a Novel Automated Immunoassay to Streamline Batch TestingDec 8 - Using Acceleration Levers to Expedite Late Phase CMC Programs for Therapeutic ProteinsDec 16 - Unlocking mRNA Performance: How Sequence Engineering and GMP Integration Accelerate Therapeutic SuccessDec
More news about: Xtalks
Dec 03, 2025, 08:30 ET Unlocking mRNA Performance: How Sequence Engineering and GMP Integration Accelerate Therapeutic Success, Upcoming Webinar Hosted by Xtalks
sequence design and GMP production and strategies to avoid them. The speakers will share insights into workflows that improve handoffs between R&D, CMC and GMP teams, reducing technical risk and accelerating timelines.TORONTO, Dec.
More news about: Xtalks
Dec 02, 2025, 11:34 ET Xtalks Announces its Life Science Webinar Calendar for December 2025
CHAINDec 4 - Using a Novel Automated Immunoassay to Streamline Batch TestingDec 8 - Using Acceleration Levers to Expedite Late Phase CMC Programs for Therapeutic ProteinsDec 16 - Unlocking mRNA Performance: How Sequence Engineering and GMP Integration Accelerate Therapeutic SuccessDec
More news about: Xtalks
Dec 02, 2025, 08:57 ET Tiger Group Offers Assets from Turf Company's Georgia Plant
rugby, tennis and field hockey.Highlights of the December 11 auction include:MANUFACTURING & INSTALL2008 CMC half-gauge, single-feed tufter with PIV yarn drive and 365 position, two-story creel2022 Zhejian Tianzhu textile machinery yarn twister (less
More news about: Tiger Group
Dec 01, 2025, 16:15 ET Commercial Metals Completes Acquisition of Concrete Pipe & Precast, LLC
calendar 2025. Following the completion of both purchases, CMC will operate one of the largest precast concrete platforms in the United States and will be a leader across the Mid-Atlantic and Southeastern regions.About CMCCMC is an innovative solutions provider helping build a stronger,
More news about: Commercial Metals Company
Dec 01, 2025, 14:15 ET Telix Pharmaceuticals (TLX) Faces Securities Class Action After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman
PET imaging agent. The CRL, a formal rejection of the application, identified "deficiencies relating to the Chemistry, Manufacturing, and Controls (CMC) package."Crucially, the FDA additionally "documented notices of deficiency (Form 483) issued to two third-party manufacturing and supply chain
More news about: Hagens Berman Sobol Shapiro LLP